Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Chronic Circadian Disruption vs. Chronic Sleep Restriction on Metabolism

NCT02171273 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT02171273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02171273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Chronic Circadian Disruption vs. Chronic Sleep Restriction on Metabolism
Lead sponsor
Brigham and Women's Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2014
Completion date
April 1, 2019
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, circadian disruption, sleep restriction